Article(id=1329906037622157633, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329906013798510609, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.11.014, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1715529600000, receivedDateStr=2024-05-13, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003907827, onlineDateStr=2026-11-18, pubDate=1762704000000, pubDateStr=2025-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003907827, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003907827, creator=13701087609, updateTime=1795003907827, updator=13701087609, issue=Issue{id=1329906013798510609, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='11', pageStart='1371', pageEnd='1492', issueExtLink='null', onlineDate='null', pubDate='1762704000000', pubDateStr='2025-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003902148, creator='13701087609', updateTime=1795004321601, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329907773602640347, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329906013798510609, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329907773606834652, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329906013798510609, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1464, endPage=1470, ext={EN=ArticleExt(id=1329906037810901314, articleId=1329906037622157633, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Pharmaceutical Research Considerations for Small-molecule Components in Antibody-drug Conjugates, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Junwei MA, Yonghui LIU, Lianjie REN*, authorsList=Junwei MA, Yonghui LIU, Lianjie REN, authorCompany=null, correspAuthors=Lianjie REN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329906038075142467, articleId=1329906037622157633, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=抗体偶联药物的小分子部分药学研究考虑, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

抗体偶联药物(ADCs)通过将高活性有效载荷精准递送至靶细胞,实现了对细胞的特异性杀伤。通常,有效载荷先通过连接子化学结合形成有效载荷-连接子复合物,再与抗体偶联,组装为完整ADCs。目前全球已上市的ADCs均用于肿瘤治疗。在我国,ADCs作为生物制品进行注册管理,其中的有效载荷-连接子部分通常被视为传统小分子化合物。因此,ADCs的研发与评价涉及多学科协同合作。目前,我国已发布了与ADCs相关的药学技术指导原则,明确了其中小分子部分的药学研究一般要求。该文章结合实际,从小分子部分的设计、生产工艺与控制、杂质分析、质量控制及稳定性研究等方面,深入探讨了其药学研究要点。

, authors=马骏威, 刘永辉, 任连杰*, authorsList=马骏威, 刘永辉, 任连杰, authorCompany=null, correspAuthors=任连杰, authorNote=

马骏威,副主任药师,从事化药的药学审评工作。

, correspAuthorsNote=
任连杰,主任药师,从事化药的药学审评工作。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=If6LrMgaDTF0w/sphTop+A==, magXml=Q8JOtGl/t0Qogb1JBCX+Vg==, pdfUrl=null, pdf=5xncKP5SFaJHsITe/3SLGA==, pdfFileSize=1394512, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=A0JqESLW4Pw8juqd/sVZog==, mapNumber=null, fund=null)}, authors=[Author(id=1329906038490378568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329906038578458954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038490378568, language=EN, stringName=Junwei MA, firstName=Junwei, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329906038637179211, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038490378568, language=CN, stringName=马骏威, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio={"content":"

马骏威,副主任药师,从事化药的药学审评工作。

"}, bioImg=null, bioContent=

马骏威,副主任药师,从事化药的药学审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329906038406492484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, xref=null, ext=[AuthorCompanyExt(id=1329906038414881093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329906038419075398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329906038695899469, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329906038771396943, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038695899469, language=EN, stringName=Yonghui LIU, firstName=Yonghui, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329906038834311504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038695899469, language=CN, stringName=刘永辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329906038406492484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, xref=null, ext=[AuthorCompanyExt(id=1329906038414881093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329906038419075398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329906038897226066, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329906038968529236, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038897226066, language=EN, stringName=Lianjie REN, firstName=Lianjie, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329906039027249493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038897226066, language=CN, stringName=任连杰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329906038406492484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, xref=null, ext=[AuthorCompanyExt(id=1329906038414881093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329906038419075398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])])], keywords=[Keyword(id=1329906039157272918, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, language=CN, orderNo=1, keyword=抗体偶联药物), Keyword(id=1329906039224381783, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, language=CN, orderNo=2, keyword=小分子), Keyword(id=1329906039291490648, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, language=CN, orderNo=3, keyword=有效载荷-连接子), Keyword(id=1329906039362793817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, language=CN, orderNo=4, keyword=杂质分析), Keyword(id=1329906039429902682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, language=CN, orderNo=5, keyword=质量控制)], refs=[Reference(id=1329906039530565979, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《抗体偶联药物药学研究与评价技术指导原则》的通告(2024年第14号)[EB/OL].(2024-02-07)[2025-05-01].https://www.cde.org.cn/main/news/viewInfoCommon/923172e1cf1c6eb92737c21ef3b93bc4., articleTitle=null, refAbstract=null), Reference(id=1329906039614452060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=李 静, 伍玉琳, 马翠翠, 等.抗体偶联药物的研究进展[J].华西药学杂志, 2023, 38(5): 586-592., articleTitle=null, refAbstract=null), Reference(id=1329906039677366621, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=DRAGO J Z, MODI S, CHANDARLAPATY S.Unlocking the potential of antibody-drug conjugates for cancer therapy[J].Nat Rev Clin Oncol, 2021, 18(6): 327-344., articleTitle=null, refAbstract=null), Reference(id=1329906039761252702, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《抗体偶联药物药学研究与评价技术指导原则》的通告(2024年第14号)[EB/OL].(2024-02-07)[2025-05-01].https://www.cde.org.cn/main/news/viewInfoCommon/923172e1cf1c6eb92737c21ef3b93bc4., articleTitle=null, refAbstract=null), Reference(id=1329906039828361567, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=DUCRY L, STUMP B.Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies [J].Bioconjug Chem, 2010, 21(1): 5-13., articleTitle=null, refAbstract=null), Reference(id=1329906039920636256, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=GOLI N , BOLLA K P , TALLA V.Antibody-drug conjugates (ADCs): potent biopharmaceuticals to target solid and hematological cancers- an overview [J].J Drug Delivery Sci Technol, 2018, 48: 106-117., articleTitle=null, refAbstract=null), Reference(id=1329906039991939425, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=KOSTOVA V, DÉSOS P, STARCK J B, et al.The chemistry behind ADCs [J].Pharmaceuticals (Basel), 2021, 14(5):442., articleTitle=null, refAbstract=null), Reference(id=1329906040067436898, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=吴雪瑶, 刘 阳.抗体偶联药物的研究进展[J].离子交换与吸附, 2024, 40(2): 127-137., articleTitle=null, refAbstract=null), Reference(id=1329906040134545763, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=JUNUTULA J R, RAAB H, CLARK S, et al.Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index [J].Nat Biotechnol, 2008, 26(8): 925-932., articleTitle=null, refAbstract=null), Reference(id=1329906040201654628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=SU Z, XIAO D, XIE F, et al.Antibody-drug conjugates:recent advances in linker chemistry [J].Acta Pharm Sin B,2021, 11(12): 3889-3907., articleTitle=null, refAbstract=null), Reference(id=1329906040272957797, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=van DELFT F, LAMBERT J M.Chemical linkers in antibody-drug conjugates (ADCs) [M].London: The Royal Society of Chemistry, 2021., articleTitle=null, refAbstract=null), Reference(id=1329906040356843878, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=TSUCHIKAMA K, AN Z Q.Antibody-drug conjugates:recent advances in conjugation and linker chemistries[J].Protein Cell, 2018, 9(1): 33-46., articleTitle=null, refAbstract=null), Reference(id=1329906040419758439, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=COLOMBO R, TARANTINO P, RICH J R, et al.The journey of antibody-drug conjugates: lessons learned from 40 years of development [J].Cancer discovery, 2024, 14(11):2089-2108., articleTitle=null, refAbstract=null), Reference(id=1329906040482673000, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Regulatory considerations for antibody-drug conjugates[EB/OL].https://fda.report/media/85350/rjorie-Shapiro--Ph.D.-%28OBP%29--October-18--2012--AAPS-Annual-Meeting.pdf., articleTitle=null, refAbstract=null), Reference(id=1329906040549781865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=戴逸飞, 谢雨佳, 杨 娇, 等.抗体偶联药物新药临床研究申请阶段药学研究关注点[J].中国新药杂志, 2025,34(1): 35-42., articleTitle=null, refAbstract=null), Reference(id=1329906040612696426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=ERICKSON H K, WIDDISON W C, MAYO M F, et al.Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates [J].Bioconjug Chem, 2010, 21(1): 84-92., articleTitle=null, refAbstract=null), Reference(id=1329906040679805291, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=AB O, WHITEMAN K R, BARTLE L M, et al.IMGN853,a folate receptor-α (FRα)-targeting antibody-drug conjugate,exhibits potent targeted antitumor activity against FRα-expressing tumors [J].Mol Cancer Ther, 2015, 14(7): 1605-1613., articleTitle=null, refAbstract=null), Reference(id=1329906040755302764, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH A P, SHARMA S, SHAH D K.Quantitative characterization of in vitro bystander effect of antibody-drug conjugates [J].J Pharmacokinet Pharmacodyn, 2016,43(6): 567-582., articleTitle=null, refAbstract=null), Reference(id=1329906040818217325, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.ICH harmonised guideline: good manufacturing practice guide for active pharmaceutical ingredients Q7 [EB/OL].[2025-05-01].https://www.cde.org.cn/ichWeb/guideIch/downloadAtt/2/ba5110faef2acef5072ec3e58ab22cc0., articleTitle=null, refAbstract=null), Reference(id=1329906040889520494, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.ICH harmonised guideline: development and manufacture of drug substances (chemical entities and biotechnological/biological entities) Q11 [EB/OL].[2025-05-01].https://www.cde.org.cn/ichWeb/guideIch/downloadAtt/2/6ea3d10b2be92c29e5e0214801eeae25., articleTitle=null, refAbstract=null), Reference(id=1329906040952435055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.ICH harmonised guideline: impurities in new drug substances Q3A(R2) [EB/OL].[2025-05-01].https://database.ich.org/sites/default/files/Q3A_R2__Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1329906041032126832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.ICH harmonised guideline: assessment and control of DNA reactive(Mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7(R1) [EB/OL].[2025-05-01].https://www.ema.europa.eu/en/ich-m7-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit-potential-carcinogenic-risk-scientific-guideline., articleTitle=null, refAbstract=null), Reference(id=1329906041090847089, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.ICH harmonised tripartite guideline: specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances Q6A [EB/OL].[2025-05-01].https://www.ema.europa.eu/en/ich-q6a-specifications-test-procedures-acceptance-criteria-new-drug-substances-new-drug-products-chemical-substances-scientific-guideline., articleTitle=null, refAbstract=null), Reference(id=1329906041153761650, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.ICH Harmonised Guideline: stability testing of new drug substances and products Q1A(R2) [EB/OL].[2025-05-01].https://database.ich.org/sites/default/files/ICH_Q1EWG_Step2_Draft_Guideline_2025_0411.pdf., articleTitle=null, refAbstract=null), Reference(id=1329906041216676211, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《抗体偶联药物分段生产试点注册申报技术要求》的通告(2024年第47号)[EB/OL].(2024-11-07)[2025-05-01]. https://www.cde.org.cn/main/news/viewInfoCommon/612aa2c85a18c269b8d352202865b71e., articleTitle=null, refAbstract=null), Reference(id=1329906041283785076, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MULLARD A.Antibody-oligonucleotide conjugates enter the clinic [J].Nat Rev Drug Discov, 2021, 21(1): 6-8., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329906038406492484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, xref=null, ext=[AuthorCompanyExt(id=1329906038414881093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329906038419075398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.11.014, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.11.014, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.11.014, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.11.014, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1762704000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
抗体偶联药物的小分子部分药学研究考虑
马骏威 , 刘永辉 , 任连杰 *
中国医药工业杂志 | 药学管理与信息 2025,56(11): 1464-1470
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2025 , 56 (11) : 1464 -1470
抗体偶联药物的小分子部分药学研究考虑
全屏
[Author(id=1329906038490378568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329906038578458954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038490378568, language=EN, stringName=Junwei MA, firstName=Junwei, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329906038637179211, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038490378568, language=CN, stringName=马骏威, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio={"content":"

马骏威,副主任药师,从事化药的药学审评工作。

"}, bioImg=null, bioContent=

马骏威,副主任药师,从事化药的药学审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329906038406492484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, xref=null, ext=[AuthorCompanyExt(id=1329906038414881093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329906038419075398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329906038695899469, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329906038771396943, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038695899469, language=EN, stringName=Yonghui LIU, firstName=Yonghui, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329906038834311504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038695899469, language=CN, stringName=刘永辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329906038406492484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, xref=null, ext=[AuthorCompanyExt(id=1329906038414881093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329906038419075398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1329906038897226066, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329906038968529236, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038897226066, language=EN, stringName=Lianjie REN, firstName=Lianjie, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329906039027249493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, authorId=1329906038897226066, language=CN, stringName=任连杰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329906038406492484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, xref=null, ext=[AuthorCompanyExt(id=1329906038414881093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076), AuthorCompanyExt(id=1329906038419075398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329906037622157633, companyId=1329906038406492484, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])])]
马骏威, 刘永辉, 任连杰*
作者信息
  • 国家药品监督管理局药品审评中心,北京 100076
通讯作者:
任连杰,主任药师,从事化药的药学审评工作。
作者简介:

马骏威,副主任药师,从事化药的药学审评工作。

Pharmaceutical Research Considerations for Small-molecule Components in Antibody-drug Conjugates
Junwei MA, Yonghui LIU, Lianjie REN*
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100076
出版时间: 2025-11-10 doi: 10.16522/j.cnki.cjph.2025.11.014
文章导航
收藏切换

抗体偶联药物(ADCs)通过将高活性有效载荷精准递送至靶细胞,实现了对细胞的特异性杀伤。通常,有效载荷先通过连接子化学结合形成有效载荷-连接子复合物,再与抗体偶联,组装为完整ADCs。目前全球已上市的ADCs均用于肿瘤治疗。在我国,ADCs作为生物制品进行注册管理,其中的有效载荷-连接子部分通常被视为传统小分子化合物。因此,ADCs的研发与评价涉及多学科协同合作。目前,我国已发布了与ADCs相关的药学技术指导原则,明确了其中小分子部分的药学研究一般要求。该文章结合实际,从小分子部分的设计、生产工艺与控制、杂质分析、质量控制及稳定性研究等方面,深入探讨了其药学研究要点。

抗体偶联药物  /  小分子  /  有效载荷-连接子  /  杂质分析  /  质量控制
马骏威, 刘永辉, 任连杰. 抗体偶联药物的小分子部分药学研究考虑. 中国医药工业杂志, 2025 , 56 (11) : 1464 -1470 . DOI: 10.16522/j.cnki.cjph.2025.11.014
Junwei MA, Yonghui LIU, Lianjie REN. Pharmaceutical Research Considerations for Small-molecule Components in Antibody-drug Conjugates[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (11) : 1464 -1470 . DOI: 10.16522/j.cnki.cjph.2025.11.014

参考文献 引证文献
排序方式:
[1]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《抗体偶联药物药学研究与评价技术指导原则》的通告(2024年第14号)[EB/OL].(2024-02-07)[2025-05-01].https://www.cde.org.cn/main/news/viewInfoCommon/923172e1cf1c6eb92737c21ef3b93bc4.
[2]
李 静, 伍玉琳, 马翠翠, 等.抗体偶联药物的研究进展[J].华西药学杂志, 2023, 38(5): 586-592.
[3]
DRAGO J Z, MODI S, CHANDARLAPATY S.Unlocking the potential of antibody-drug conjugates for cancer therapy[J].Nat Rev Clin Oncol, 2021, 18(6): 327-344.
[4]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《抗体偶联药物药学研究与评价技术指导原则》的通告(2024年第14号)[EB/OL].(2024-02-07)[2025-05-01].https://www.cde.org.cn/main/news/viewInfoCommon/923172e1cf1c6eb92737c21ef3b93bc4.
[5]
DUCRY L, STUMP B.Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies [J].Bioconjug Chem, 2010, 21(1): 5-13.
[6]
GOLI N , BOLLA K P , TALLA V.Antibody-drug conjugates (ADCs): potent biopharmaceuticals to target solid and hematological cancers- an overview [J].J Drug Delivery Sci Technol, 2018, 48: 106-117.
[7]
KOSTOVA V, DÉSOS P, STARCK J B, et al.The chemistry behind ADCs [J].Pharmaceuticals (Basel), 2021, 14(5):442.
[8]
吴雪瑶, 刘 阳.抗体偶联药物的研究进展[J].离子交换与吸附, 2024, 40(2): 127-137.
[9]
JUNUTULA J R, RAAB H, CLARK S, et al.Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index [J].Nat Biotechnol, 2008, 26(8): 925-932.
[10]
SU Z, XIAO D, XIE F, et al.Antibody-drug conjugates:recent advances in linker chemistry [J].Acta Pharm Sin B,2021, 11(12): 3889-3907.
[11]
van DELFT F, LAMBERT J M.Chemical linkers in antibody-drug conjugates (ADCs) [M].London: The Royal Society of Chemistry, 2021.
[12]
TSUCHIKAMA K, AN Z Q.Antibody-drug conjugates:recent advances in conjugation and linker chemistries[J].Protein Cell, 2018, 9(1): 33-46.
[13]
COLOMBO R, TARANTINO P, RICH J R, et al.The journey of antibody-drug conjugates: lessons learned from 40 years of development [J].Cancer discovery, 2024, 14(11):2089-2108.
[14]
FDA.Regulatory considerations for antibody-drug conjugates[EB/OL].https://fda.report/media/85350/rjorie-Shapiro--Ph.D.-%28OBP%29--October-18--2012--AAPS-Annual-Meeting.pdf.
[15]
戴逸飞, 谢雨佳, 杨 娇, 等.抗体偶联药物新药临床研究申请阶段药学研究关注点[J].中国新药杂志, 2025,34(1): 35-42.
[16]
ERICKSON H K, WIDDISON W C, MAYO M F, et al.Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates [J].Bioconjug Chem, 2010, 21(1): 84-92.
[17]
AB O, WHITEMAN K R, BARTLE L M, et al.IMGN853,a folate receptor-α (FRα)-targeting antibody-drug conjugate,exhibits potent targeted antitumor activity against FRα-expressing tumors [J].Mol Cancer Ther, 2015, 14(7): 1605-1613.
[18]
SINGH A P, SHARMA S, SHAH D K.Quantitative characterization of in vitro bystander effect of antibody-drug conjugates [J].J Pharmacokinet Pharmacodyn, 2016,43(6): 567-582.
[19]
ICH.ICH harmonised guideline: good manufacturing practice guide for active pharmaceutical ingredients Q7 [EB/OL].[2025-05-01].https://www.cde.org.cn/ichWeb/guideIch/downloadAtt/2/ba5110faef2acef5072ec3e58ab22cc0.
[20]
ICH.ICH harmonised guideline: development and manufacture of drug substances (chemical entities and biotechnological/biological entities) Q11 [EB/OL].[2025-05-01].https://www.cde.org.cn/ichWeb/guideIch/downloadAtt/2/6ea3d10b2be92c29e5e0214801eeae25.
[21]
ICH.ICH harmonised guideline: impurities in new drug substances Q3A(R2) [EB/OL].[2025-05-01].https://database.ich.org/sites/default/files/Q3A_R2__Guideline.pdf.
[22]
ICH.ICH harmonised guideline: assessment and control of DNA reactive(Mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7(R1) [EB/OL].[2025-05-01].https://www.ema.europa.eu/en/ich-m7-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit-potential-carcinogenic-risk-scientific-guideline.
[23]
ICH.ICH harmonised tripartite guideline: specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances Q6A [EB/OL].[2025-05-01].https://www.ema.europa.eu/en/ich-q6a-specifications-test-procedures-acceptance-criteria-new-drug-substances-new-drug-products-chemical-substances-scientific-guideline.
[24]
ICH.ICH Harmonised Guideline: stability testing of new drug substances and products Q1A(R2) [EB/OL].[2025-05-01].https://database.ich.org/sites/default/files/ICH_Q1EWG_Step2_Draft_Guideline_2025_0411.pdf.
[25]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《抗体偶联药物分段生产试点注册申报技术要求》的通告(2024年第47号)[EB/OL].(2024-11-07)[2025-05-01]. https://www.cde.org.cn/main/news/viewInfoCommon/612aa2c85a18c269b8d352202865b71e.
[26]
MULLARD A.Antibody-oligonucleotide conjugates enter the clinic [J].Nat Rev Drug Discov, 2021, 21(1): 6-8.
2025年第56卷第11期
31
7
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.11.014
  • 接收时间:2024-05-13
  • 首发时间:2026-11-18
  • 出版时间:2025-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-05-13
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100076

通讯作者:

任连杰,主任药师,从事化药的药学审评工作。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.11.014
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏